| Dr Joseph N Foss, MD | |
|
52 W Underwood St, Orlando, FL 32806-1110 | |
| (321) 842-8475 | |
| (407) 849-6470 |
| Full Name | Dr Joseph N Foss |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 32 Years |
| Location | 52 W Underwood St, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013904192 | NPI | - | NPPES |
| 42950 | Other | FL | BCBS |
| 254232300 | Medicaid | FL | |
| 42950W | Other | FL | MEDICARE PTAN OHRI |
| PS285 | Other | FL | MEDICARE PTAN OHMG |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | ME68581 (Florida) | Primary |
| 2085P0229X | Radiology - Pediatric Radiology | ME68581 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orlando Health | Orlando, FL | Hospital |
| Orlando Health South Lake Hospital | Clermont, FL | Hospital |
| Bayfront Health - St Petersburg | Saint petersburg, FL | Hospital |
| St Cloud Regional Medical Center | Saint cloud, FL | Hospital |
| Health Central | Ocoee, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohri Llc | 4981912169 | 92 |
| Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
A new study in animals shows that using a compound to block the body's immune response greatly reduces disability after a stroke.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
The COSHAR Foundation has enhanced its national immunization awareness campaign, Protecting our Future: The COSHAR Foundation Immunization Project, by updating its free immunization toolkits with new materials, including updated information about autism and vaccines and information on H1N1 flu. The new toolkits are available now.
› Verified 1 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
A new study in animals shows that using a compound to block the body's immune response greatly reduces disability after a stroke.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
The COSHAR Foundation has enhanced its national immunization awareness campaign, Protecting our Future: The COSHAR Foundation Immunization Project, by updating its free immunization toolkits with new materials, including updated information about autism and vaccines and information on H1N1 flu. The new toolkits are available now.
› Verified 1 days ago
| Entity Name | Ohri Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386034346 PECOS PAC ID: 4981912169 Enrollment ID: O20151008000809 |
News Archive
A new study in animals shows that using a compound to block the body's immune response greatly reduces disability after a stroke.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
The COSHAR Foundation has enhanced its national immunization awareness campaign, Protecting our Future: The COSHAR Foundation Immunization Project, by updating its free immunization toolkits with new materials, including updated information about autism and vaccines and information on H1N1 flu. The new toolkits are available now.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph N Foss, MD 52 W Underwood St, Orlando, FL 32806-1110 Ph: (321) 842-8475 | Dr Joseph N Foss, MD 52 W Underwood St, Orlando, FL 32806-1110 Ph: (321) 842-8475 |
News Archive
A new study in animals shows that using a compound to block the body's immune response greatly reduces disability after a stroke.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
The COSHAR Foundation has enhanced its national immunization awareness campaign, Protecting our Future: The COSHAR Foundation Immunization Project, by updating its free immunization toolkits with new materials, including updated information about autism and vaccines and information on H1N1 flu. The new toolkits are available now.
› Verified 1 days ago
Rola Altoos, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-200-2355 | |
Steven D. Beesley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 86 W Underwood St, Suite 201, 2nd Floor, Orlando, FL 32806 Phone: 321-841-5142 Fax: 407-648-3686 | |
Alan M Litwin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9037 Point Cypress Dr, Orlando, FL 32836 Phone: 813-745-7365 Fax: 813-449-8618 | |
Dr. Robert C Hudak, MD Radiology Medicare: Medicare Enrolled Practice Location: 20 W Kaley St, Orlando, FL 32806 Phone: 407-423-2581 Fax: 407-849-6470 | |
Dr. Christopher T Rush, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-5600 Fax: 317-705-5047 | |
Dr. John Franklin Hoy, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 13800 Veterans Way, Orlando, FL 32827 Phone: 407-631-1120 |